StonvexLoading…
StonvexStonvexStonvexCore line items from SCSC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $3.04B | $3.26B | $3.79B | $3.53B |
Operating Income | $85.20M | $90.32M | $135.89M | $122.17M |
Net Income | $71.55M | $77.06M | $89.81M | $88.80M |
EPS (Diluted) | $3.00 | $3.06 | $3.54 | $3.45 |
Total Assets | $1.79B | $1.78B | $2.07B | $1.94B |
Total Liabilities | $879.20M | $854.78M | $1.16B | $1.13B |
Cash & Equivalents | $126.16M | $185.46M | $36.18M | $37.99M |
Free Cash Flow OCF − CapEx | $104.06M | $363.09M | $-45.75M | $-131.20M |
Shares Outstanding | 22.22M | 24.24M | 24.84M | 25.19M |